| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |